Results
|
1641.
|
|
|
1642.
|
|
|
1643.
|
|
|
1644.
|
|
|
1645.
|
|
|
1646.
|
|
|
1647.
|
|
|
1648.
|
Total integrated performance excellence system (TIPES): A true north direction for a clinical trial support center. [electronic resource] by
- Sather, Mike R
- Parsons, Sherry
- Boardman, Kathy D
- Warren, Stuart R
- Davis-Karim, Anne
- Griffin, Kevin
- Betterton, Jane A
- Jones, Mark S
- Johnson, Stanley H
- Vertrees, Julia E
- Hickey, Jan H
- Salazar, Thelma P
- Huang, Grant D
Publication details: Contemporary clinical trials communications Mar 2018
In:
Contemporary clinical trials communications vol. 9
Availability: No items available.
|
|
1649.
|
|
|
1650.
|
|
|
1651.
|
GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis. [electronic resource] by
- Naiki, Taku
- Naiki-Ito, Aya
- Iida, Keitaro
- Etani, Toshiki
- Kato, Hiroyuki
- Suzuki, Shugo
- Yamashita, Yoriko
- Kawai, Noriyasu
- Yasui, Takahiro
- Takahashi, Satoru
Publication details: Oncotarget Mar 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
1652.
|
|
|
1653.
|
|
|
1654.
|
An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphoma. [electronic resource] by
- Li, Ling
- Xiao, Sa
- Zhang, Lei
- Li, Xin
- Fu, Xiaorui
- Wang, Xinhua
- Wu, Jingjing
- Sun, Zhenchang
- Zhang, Xudong
- Chang, Yu
- Nan, Feifei
- Yan, Jiaqin
- Li, Zhaoming
- Shi, Mengyuan
- Young, Ken H
- Zhang, Mingzhi
Publication details: Oncotarget Mar 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
1655.
|
|
|
1656.
|
|
|
1657.
|
|
|
1658.
|
|
|
1659.
|
|
|
1660.
|
|